U.S. President Donald Trump has signed an executive order directing federal agencies to loosen regulations on marijuana, a move that could mark one of the most significant changes in U.S. cannabis policy in decades. The order instructs the attorney general to move quickly toward reclassifying marijuana under the Controlled Substances Act, potentially shifting it from Schedule I to Schedule III.
If reclassified, marijuana would be grouped with drugs such as certain painkillers, ketamine, and testosterone, which are considered to have accepted medical uses and lower abuse potential. While marijuana would remain illegal at the federal level, the change could dramatically reshape the cannabis industry by expanding medical research opportunities, improving access to funding, and easing barriers for banks and institutional investors.
Trump defended the decision by emphasizing patient needs, saying many Americans suffering from chronic pain have pushed for greater access to marijuana-based treatments. Although he reiterated that he does not personally use the drug and remains cautious about controlled substances, he acknowledged its growing demand and medical relevance.
The move drew mixed reactions in Washington. Senate Democratic Leader Chuck Schumer welcomed the order, calling it a step toward long-overdue reform. In contrast, dozens of Republican lawmakers urged Trump not to proceed, arguing that reclassification could send the wrong message to children, empower drug cartels, and increase safety risks on U.S. roads.
Industry experts noted that congressional action would still be required to establish stable nationwide cannabis regulations. The Drug Enforcement Administration must now review the recommendation, a process that has historically been slowed by bureaucracy. Even with reclassification, marijuana would still face federal restrictions and criminal penalties.
Cannabis stocks initially rose on the news but later fell as investors realized the order did not include provisions for cannabis banking reform. Limited access to traditional financing remains a major challenge for marijuana companies, contributing to high operating costs and the persistence of black-market activity.
Public opinion continues to favor legalization, with most Americans supporting broader reform. Combined with previous efforts, including reviews initiated under former President Joe Biden, Trump’s order signals a continued shift toward easing long-standing federal marijuana policies while leaving the final outcome uncertain.


SEC Moves to Dismiss Insider Trading Case Against Trump-Pardoned Terren Peizer
US Expands Social Media Vetting to Foreign Journalists Seeking Visas
Trump Administration to Ban Chinese Robots, Power Inverters Over AI Security Concerns
Brazil Rejects Visas for Trump Officials Ahead of Presidential Election
US Expects Iran-Oman Hormuz Shipping Deal Soon
Mark Carney Jokes About Teleprompter, Takes Swipe at Trump
Russian Strikes Kill Six in Eastern and Northern Ukraine, Dozens Injured
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
Trump Orders Section 301 Probe Into EU Tech Fines, Signals New Tariffs
Colombia President Abelardo De La Espriella Pledges Drug Crackdown, Economic Reforms
ICE to Complete Nationwide Body Camera Rollout by End of August
Ukraine Agrees to Protect Kazakhstan Oil Exports via Black Sea
Trump Orders Probe Into Pentagon Munitions Stockpile Leaks After Iran Conflict
Zelensky Urges Faster NATO Action on Air Defense Missiles
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Joe Biden’s Prostate Cancer Has Spread Further, Hunter Biden Says 



